Results 261 to 270 of about 84,619 (287)

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Lancet, The, 2022
Parvinder Aley, Sue Charlton, Christopher J A Duncan   +2 more
exaly  

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Science, 2022
Catherine J Reynolds, Joseph M Gibbons, Corinna Pade   +2 more
exaly  

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Denis Y Logunov, Inna V Dolzhikova, Olga Zubkova   +2 more
exaly  

Homologous and Heterologous Covid-19 Booster Vaccinations

New England Journal of Medicine, 2022
Robert L Atmar, Kirsten E Lyke, Meagan Bolles   +2 more
exaly  

Catalytic antibodies generated via heterologous immunization

Journal of the American Chemical Society, 1994
Hiroaki Suga, Oguz Ersoy, Simon F. Williams, Takeshi Tsumuraya, Michael N. Margolies, Anthony J. Sinskey, Satoru Masamune   +6 more
openaire   +1 more source

Heterologous Immunity Pushes Boundaries

Microbe Magazine, 2009
openaire   +1 more source

Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Nature Medicine, 2021
Tina Schmidt, David Schub, Janine Mihm
exaly  

Cellular immunity to heterologous erythrocytes in vitro

Cellular Immunology, 1973
I Weissman, D Lannin, L Jerabek, T Barclay   +3 more
openaire   +1 more source

No one is naive: the significance of heterologous T-cell immunity

Nature Reviews Immunology, 2002
Liisa K Selin
exaly  

Immunisation against heterologous type II collagen induces arthritis in mice

Nature, 1980
Margaret Dallman
exaly